OR WAIT null SECS
September 19, 2023
The agency’s work with EUnetHTA 21 helped it to prepare the EU for implementation of the regulation.
Iopofosine provides targeted delivery of idodine-131 directly to cancer cells.
September 18, 2023
The EMA’s Committee for Medicinal Products for Human Use has given a positive opinion on Sandoz’ biosimilar trastuzumab for breast and gastric cancer.
September 15, 2023
The safety profile of erdafitinib observed in THOR was consistent with the previously reported safety profile of erdafitinib in metastatic urothelial carcinoma (mUC).
September 11, 2023
Topiramate can cause serious birth defects if exposed to children in the womb.
September 03, 2023
Tumour-infiltrating lymphocyte (TIL) therapies offer a new route to target cancer.
September 02, 2023
European vaccine manufacturing is being boosted with high level investments.
August 31, 2023
The updated vaccine will be ready to ship following a positive European Commission review.
August 30, 2023
The new products aim to aid consumers with menopause and eye health-related issues.
August 29, 2023
Rentschler Biopharma, CGT Catapult, and Refeyn aim to use automated and digital technologies to improve AAV manufacturing for gene therapies.